Items stated in the management plan
FormulatedEach line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. For metrics expressed as percentages, differences are shown in percentage points (pt).The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
To clarify the two pillars of our growth strategy, namely the growth of our domestic business and the development of markets in Southeast Asia, following the full-scale launch of our Singapore business.
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan |
| Plan period | Fiscal years ending March 2027 to March 2030 |
| Progress against the plan | Formulated |
| Sales Target | 2,811 (actual for the fiscal year ending March 2026) → 5,500 (target for the fiscal year ending March 2030) |
| Operating profit target | 202 (actual for the fiscal year ending March 2026) → 1,000 (target for the fiscal year ending March 2030) |
| Operating profit margin target | 7.2% (actual for the fiscal year ending March 2026) → 18.2% (target for the fiscal year ending March 2030) |
| Key initiatives | Domestic Business Growth, Development of markets in Southeast Asia, Sustained revenue growth by increasing the number of stored specimens in both Japan and overseas, Creation of new business opportunities in related fields, including regenerative medicine and cell therapy |
| Reason for revision or withdrawal | To clarify the two pillars of our growth strategy, namely the growth of our domestic business and the development of markets in Southeast Asia, following the full-scale launch of our Singapore business. |
| Publication date | 13 May 2026 |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To clarify the two pillars of our growth strategy, namely the growth of our domestic business and the development of markets in Southeast Asia, following the full-scale launch of our Singapore business. To achieve sustained medium- to long-term growth in results and enhance corporate value.